Kolb, H J <br/><br/>
Donor leukocyte transfusions for treatment of leukemic relapse after bone marrow transplantation. EBMT Immunology and Chronic Leukemia Working Parties.  [electronic resource] 

 -  Vox sanguinis  1998 
 - 321-9 p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>0042-9007 
<br/><br/><label>Standard No.: </label>10.1111/j.1423-0410.1998.tb05438.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antineoplastic Agents--therapeutic use<br/>Bone Marrow Transplantation<br/>Chimera<br/>Combined Modality Therapy<br/>Cytokines--therapeutic use<br/>Disease-Free Survival<br/>Dogs<br/>Female<br/>Graft vs Tumor Effect<br/>Growth Inhibitors--therapeutic use<br/>Hematopoietic Cell Growth Factors--therapeutic use<br/>Hematopoietic Stem Cell Transplantation<br/>Humans<br/>Immunologic Factors--therapeutic use<br/>Immunotherapy, Adoptive<br/>Interferon-alpha--therapeutic use<br/>Leukemia--mortality<br/>Leukemia, Experimental--therapy<br/>Leukemia, Myelogenous, Chronic, BCR-ABL Positive--therapy<br/>Leukocyte Transfusion<br/>Life Tables<br/>Male<br/>Recurrence<br/>Remission Induction<br/>Retrospective Studies<br/>Salvage Therapy<br/>Survival Analysis<br/>Transplantation Conditioning<br/>Treatment Outcome